FDA Approved: BEVESPI AEROSPHERE — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved Bevespi Aerosphere, a fixed-dose inhalation combination of glycopyrrolate and formoterol fumarate, under its original application for chronic obstr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Bevespi Aerosphere (glycopyrrolate/formoterol fumarate)

Snippet

ORIG AP for BEVESPI AEROSPHERE (GLYCOPYRROLATE AND FORMOTEROL FUMARATE)